Skip to main content

Dexcom

By Adam Ang | 10:39 pm | February 23, 2023
Also, medical device unicorn Molbio has taken a 70% stake in digital x-ray manufacturer Prognosys.
By Emily Olsen | 11:45 am | February 09, 2023
The partnership allows DarioHealth to integrate data from Dexcom's continuous glucose monitors in its chronic-condition management platform.
By Emily Olsen | 11:54 am | December 13, 2022
The company said it plans to launch the latest model of its CGM in early 2023.
By Laura Lovett | 02:57 pm | January 13, 2022
The company also unveiled its 2021 revenue. 
By Emily Olsen | 12:28 pm | October 15, 2021
Garmin’s new apps allow people using the Dexcom G6 CGM to see glucose levels and trends on their smartwatch.
By Mallory Hackett | 12:18 pm | July 16, 2021
Dexcom’s Partner Web APIs will allow users to view all of their diabetes care data in one place to enable in-the-moment feedback and adjustments.   
By Mallory Hackett | 03:47 pm | June 25, 2021
Experts say that time in range metrics can provide more actionable insights than A1C levels.   
By Mallory Hackett | 12:26 pm | May 06, 2021
Eli Lilly’s Tempo Pen and connected Tempo Smart Button will integrate with the software platforms and/or medical devices offered by the diabetes management companies.
By Mallory Hackett | 03:32 pm | April 30, 2021
As of Friday afternoon, Dexcom’s stock has fallen 6.3% from about $422 to $395.   
By Dave Muoio | 04:26 pm | March 23, 2021
Also: Dexcom promotes Jereme Sylvain to EVP and CFO; Amalgam Rx snags CMS' Jennifer Main as COO and CFO.